Is there such a thing as “pre-gestational diabetes”? Steve Freed asks and Lynne Raphael, RD, CDE, and Cathy Wielgus, RN, CDE, explain that, ideally, women should begin managing their diabetes before conception, in order to maximize the chances of having a normal weight baby. However, many of the women who they …
Read More »Lynne Raphael, RD, CDE, and Cathy Wielgus, RN, CDE: What Are the Latest Guidelines for Diabetes in Pregnancy?
Lynne Raphael, MMSc, RD, LD, CDE, and Cathy Wielgus, MSN, BSN, RN, CDE, discuss the latest guidelines for diabetes in pregnancy and how clinicians can help their patients adhere to these rules….
Read More »Lynne Raphael, RD, CDE, and Cathy Wielgus, RN, CDE: What Does Intensive Management of Diabetes in Pregnancy Mean?
Lynne Raphael, RD, CDE, and Cathy Wielgus, RN, CDE, talk about what intensive management of diabetes in pregnancy actually means. Most attention in the past has focused on the mother’s health, and diabetes management has not always included the fetus. Now, research is showing that GDM can affect the health …
Read More »Lynne Raphael, MMSc, RD, LD, CDE, and Cathy Wielgus, MSN, BSN, RN, CDE, Introduction
Lynne Raphael, MMSc, RD, LD, CDE, and Cathy Wielgus, MSN, BSN, RN, CDE, introduce themselves and explain a little about their presentation (at the 2012 AADE) on, “Innovative Strategies for the Intensive Management of Diabetes in Pregnancy.” More videos with Lynne Raphael and Cathy Wielgus: What Does Intensive Management of Diabetes …
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #2:Adjunctive Therapies, Part 1 of 3
Anne Peters, MD, and Lori Laffel, MD, MPH, editors Jane Lee Chiang, MD, managing editor Introduction Jeremy Hodson Pettus, MD, and Steven Edelman, MD The discovery of insulin over 90 years ago remains one of the greatest success stories in the history of medicine.
Read More »Quality Measures in Cholesterol and Diabetes Management, Part 4 of 4
This week, we wrap up our series of Homerun Slides on Quality Measures, with summaries of the commonalities and differences across both cholesterol and diabetes measures, as well as a comparison between the two….
Read More »Liptruzet® – A Lipid-lowering Combination
Liptruzet® – A Lipid-lowering Combination The FDA has approved a new lipid-lowering combination tablet (Liptruzet) that includes atorvastatin and ezetimibe. The tablet is available as a once-daily tablet containing 10 mg of ezetimibe combined with 10, 20, 40, or 80 mg of atorvastatin, can be used to treat elevated …
Read More »Diabetes Increases Cancer Risk by 20 Percent
Joint research by the Japan Diabetes Society and the Japanese Cancer Association has found that people with diabetes run a 20 percent higher risk of contracting cancer….
Read More »Infection Linked to Injecting through Clothing
After extending incubation period for cultures, non-tuberculous mycobacteria cutaneous infection was found on woman injecting insulin through clothing….
Read More »Nutritional Effects on Measurement of Insulin Sensitivity
Partial replacement of carbohydrates with unsaturated fat may improve insulin sensitivity in a population at risk for cardiovascular disease….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.